The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Nea 16 Gp, Llc since year 2005.
The trader's CIK number is 1712882.
At the time of the last reporting, Nea 16 Gp, Llc was the 10% Owner of Mirum Pharmaceuticals, Inc. .
(stock ticker symbol MIRM).
See this page for all insider trading activities at Mirum Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-22||MIRM||Mirum Pharmaceuticals, Inc.||Buy||450,000||15.00||6,750,000|
|2019-06-24||GNCA||Genocea Biosciences, Inc.||Buy||2,857,142||3.50||9,999,997|
|2019-05-09||TRVI||Trevi Therapeutics, Inc.||Buy||2,500,000||10.00||25,000,000|
|2019-05-07||RGLS||Regulus Therapeutics Inc.||Buy||1,136,704||1.08||1,227,640|
|2019-02-14||GNCA||Genocea Biosciences, Inc.||Buy||9,948,269||.47||4,685,634|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nea 16 Gp, Llc (10% Owner of Mirum Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.